Hey KP, just wondering why can’t they sign the deal, and make the additional equity issue as a condition precedent? And they tell the market that we have a deal subject to shareholders’ approval of the additional share issue? In that scenario, the market will gladly approve the issue without a fuss. I see plenty of times agreement are signed, subject to X Y Z being ticked off before it comes into effect. Surely PAR could have been more transparent but they chose maximum opacity. To what ends, one can only speculate and it leaves room for people to, rightly or wrongly, conclude another CR is on the agenda.
- Forums
- ASX - By Stock
- PAR
- Ann: Notice of General Meeting/Proxy Form
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.84%
!
29.5¢

Ann: Notice of General Meeting/Proxy Form, page-50
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $114.8M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 29.0¢ | $67.50K | 220.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 44652 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 0.290 |
7 | 110688 | 0.285 |
20 | 268416 | 0.280 |
7 | 73263 | 0.275 |
6 | 106424 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 44652 | 7 |
0.305 | 2746 | 1 |
0.310 | 57505 | 3 |
0.315 | 59233 | 3 |
0.320 | 108906 | 8 |
Last trade - 13.04pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online